vvx001
Vaccineexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 6, 2018 (NCT03625934)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Hepatitis B virusImmunity, active
Hepatitis B virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03625934 | Phase 1/Phase 2 (Phase 2) | Aug 6, 2018 | Biomay AG, Gouya Insights, KKS MedUni Vienna, Medical University of Vienna |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Biomay AG | For profit | 1 | 1 | 1 | 2018 |
| Gouya Insights | For profit | 1 | 0 | 1 | 2018 |
| KKS MedUni Vienna | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Medical University of Vienna | Academic/Hospital | 1 | 0 | 1 | 2018 |
4 organizations
Page 1 / 1